Akebia Therapeutics, Inc. (AKBA)
Cambridge, MA
Total Compensation for Fiscal Year Ending in 2024: $4,260,114
| Salary | $833,966 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $1,013,880 |
| Value of Option Awards | $1,314,898 |
| Non-Equity Incentive Plan Compensation | $1,033,200 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $64,170 |
| Total | $4,260,114 |
Akebia Therapeutics, Inc. disclosed its CEO pay was
17
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
